2.68
price up icon4.28%   0.11
after-market アフターアワーズ: 2.75 0.07 +2.61%
loading

Iovance Biotherapeutics Inc (IOVA) 最新ニュース

pulisher
05:30 AM

Is Iovance Biotherapeutics Inc. stock overvalued or undervaluedMarket-leading growth rates - jammulinksnews.com

05:30 AM
pulisher
04:27 AM

What are Iovance Biotherapeutics Inc. company’s key revenue driversMassive wealth growth - jammulinksnews.com

04:27 AM
pulisher
02:26 AM

Will Iovance Biotherapeutics Inc. price bounce be sustainableFree Early Entry Picks Before News Breakout - Newser

02:26 AM
pulisher
Aug 02, 2025

What institutional investors are buying Iovance Biotherapeutics Inc. stockAchieve consistent profits with proven strategies - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for Iovance Biotherapeutics Inc.Invest smarter with actionable trading signals - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 01, 2025

What is the dividend policy of Iovance Biotherapeutics Inc. stockStock Market Picks With High Returns - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

A Closer Look at Iovance Biotherapeutics Inc (IOVA) Stock Gains - investchronicle.com

Aug 01, 2025
pulisher
Aug 01, 2025

Iovance Biotherapeutics: Unlocking TIL Therapy's Potential Amid Funding Challenges - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Iovance Biotherapeutics (IOVA): Promising TIL Therapy Gains Momentum Amid Funding Challenges - Yahoo Finance

Aug 01, 2025
pulisher
Aug 01, 2025

Day 6 of Loss Streak for Iovance Biotherapeutics Stock with -35% Return (vs. -65% YTD) [7/31/2025] - Trefis

Aug 01, 2025
pulisher
Aug 01, 2025

Iovance Biotherapeutics (IOVA) Gets Downgraded to Sell from Neutral at Goldman Sachs - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

Intraday pattern recognizer results for Iovance Biotherapeutics Inc.Real-Time Setup Summary with ROI Focus - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Iovance Biotherapeutics: Recent Clinical Study Results and Leadership Appointments Boost Growth Prospects - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Iovance Biotherapeutics shares rise 4.12% premarket after Eisai and Biogen's Alzheimer's drug LEQEMBI shows sustained long-term benefits. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Exit strategy if you’re trapped in Iovance Biotherapeutics Inc.Chart Driven Entry Timing for Swing Trades - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What is the risk reward ratio of investing in Iovance Biotherapeutics Inc. stockEarnings Report Planner For 2025 - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Iovance Biotherapeutics Inc. Building a Base Near SupportSwing Trade Entry Alert Analysis - beatles.ru

Jul 31, 2025
pulisher
Jul 31, 2025

What moving averages say about Iovance Biotherapeutics Inc.Real Time Growth Signal with Smart Setup - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Day 5 of Loss Streak for Iovance Biotherapeutics Stock with -33% Return (vs. -64% YTD) [7/30/2025] - Trefis

Jul 31, 2025
pulisher
Jul 30, 2025

Market Shock Waves: Iovance Biotherapeutics’ Sudden Challenges - timothysykes.com

Jul 30, 2025
pulisher
Jul 30, 2025

Iovance Biotherapeutics Faces Market Challenges Amid Financial Setbacks - StocksToTrade

Jul 30, 2025
pulisher
Jul 30, 2025

Is Iovance Biotherapeutics Stock Due for a Big Rally? - Mitrade

Jul 30, 2025
pulisher
Jul 30, 2025

Using AI based signals to follow Iovance Biotherapeutics Inc.Chart Pattern Recognition for Profit Timing - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Can Iovance Biotherapeutics Inc. rally from current levelsShort-Term Profit Alert With Entry Forecast - newser.com

Jul 30, 2025
pulisher
Jul 30, 2025

How to monitor Iovance Biotherapeutics Inc. with trend dashboardsReliable Setup Screener with Low Risk - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Is Iovance Biotherapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Optimized Watchlist With Daily Adjustments - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why Iovance Biotherapeutics Inc. stock attracts strong analyst attentionReal Time Trade Execution Alert Plan - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Iovance Biotherapeutics Inc. Company Revenue and Profit Trends: A Deep DiveWatchlist for Low Risk High Return Stocks Updated - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Price momentum metrics for Iovance Biotherapeutics Inc. explainedMomentum Prediction Based on AI Backtesting - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Is Iovance Biotherapeutics a Buy on the Dip? Assessing the Risk/Reward of Autologous Cell Therapy Commercialization - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Iovance Biotherapeutics shares rise 2.03% premarket after UK's MHRA approves Tofersen for rare motor neurone disease. - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy? - Yahoo Finance

Jul 29, 2025
pulisher
Jul 28, 2025

Iovance Biotherapeutics’ SWOT analysis: stock faces challenges amid promising data - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Iovance Biotherapeutics Inc.Turbocharged investment results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Iovance Biotherapeutics Inc. stock perform well during market downturnsRecord-breaking capital gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How Iovance Biotherapeutics Inc. stock performs during market volatilitySwing Entry Risk Mitigation with Chart Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Iovance Biotherapeutics Inc. in the next 12 monthsSkyrocketing profit margins - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Iovance Biotherapeutics Inc. Stock a Good Fit for Conservative InvestorsDaily Top Gainers - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Acquired by Bank of New York Mellon Corp - Defense World

Jul 27, 2025
pulisher
Jul 27, 2025

Levi & Korsinsky Notifies Shareholders of Iovance Biotherapeutics, Inc.(IOVA) of a Class Action Lawsuit and an Upcoming Deadline - Kilgore News Herald

Jul 27, 2025
pulisher
Jul 25, 2025

Iovance Biotherapeutics Plummets Amidst Lawsuit and Executive Shake-up - timothysykes.com

Jul 25, 2025
pulisher
Jul 25, 2025

Decoding Iovance Biotherapeutics: A TIL Breakout or Premature Optimism? - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Iovance Biotherapeutics Is Waking UpPrice Action Screams Breakout, But Fundamentals Demand Patience - Seeking Alpha

Jul 25, 2025
pulisher
Jul 25, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Held Back By Insufficient Growth Even After Shares Climb 75% - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

Iovance Biotherapeutics Soars 13.37% on FDA Approval, Buy Rating - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Iovance Biotherapeutics Inc. stockUnprecedented market success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Iovance Biotherapeutics shares rise 5.47% premarket after Pfizer's $1.25 billion licensing agreement for cancer drug. - AInvest

Jul 25, 2025
pulisher
Jul 24, 2025

Iovance Biotherapeutics to Host Second Quarter and First - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

About Us - FinancialContent

Jul 24, 2025
pulisher
Jul 24, 2025

Goldman Sachs Downgrade Sends Iovance Biotherapeutics Tumbling - timothysykes.com

Jul 24, 2025
pulisher
Jul 24, 2025

Iovance Biotherapeutics: A Contrarian Bet on TIL Therapy Amid Regulatory Hurdles for Rivals - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Iovance’s Big Bet On Cancer Hits Bumps, But The Payoff Could Be Huge - Finimize

Jul 24, 2025
pulisher
Jul 24, 2025

Iovance Biotherapeutics Target of Unusually Large Options Trading (NASDAQ:IOVA) - Defense World

Jul 24, 2025
pulisher
Jul 23, 2025

Iovance Biotherapeutics Benefits from Replimune FDA Setback, Maintains Buy Rating - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Iovance Biotherapeutics Stock (IOVA) Opinions on FDA Competitor Rejection - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

Here’s why Iova stock surged 32% today and why the rally might not be over - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Iova Stock Surges 23.5% Amid FDA Approval and New CEO Appointment - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Iovance Biotherapeutics’ Remarkable Surge: Time to Dive In? - StocksToTrade

Jul 23, 2025
pulisher
Jul 23, 2025

Iovance Skyrockets 29.23%—Is This the Start of a Biotech Bull Run? - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Positive Week for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Institutional Investors Who Lost 64% Over the Past Year - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

Iovance Biotherapeutics’ Unexpected Surge: Is It Time to Buy? - timothysykes.com

Jul 23, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):